NO922941L - Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener - Google Patents
Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigenerInfo
- Publication number
- NO922941L NO922941L NO92922941A NO922941A NO922941L NO 922941 L NO922941 L NO 922941L NO 92922941 A NO92922941 A NO 92922941A NO 922941 A NO922941 A NO 922941A NO 922941 L NO922941 L NO 922941L
- Authority
- NO
- Norway
- Prior art keywords
- aids
- carbohydrate
- arc
- medicinals
- procedures
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 208000030507 AIDS Diseases 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 206010001513 AIDS related complex Diseases 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47066690A | 1990-01-26 | 1990-01-26 | |
| PCT/EP1990/002161 WO1991011528A1 (fr) | 1990-01-26 | 1990-12-13 | Procedes et medicaments de traitement du syndrome d'immunodeficience acquise (sida) et du complexe apparente au sida (arc) au moyen d'anticorps anti-glucides et d'antigenes glucidiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO922941D0 NO922941D0 (no) | 1992-07-24 |
| NO922941L true NO922941L (no) | 1992-09-17 |
Family
ID=23868522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92922941A NO922941L (no) | 1990-01-26 | 1992-07-24 | Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP0511967B1 (fr) |
| JP (2) | JPH05506565A (fr) |
| AT (1) | ATE134649T1 (fr) |
| AU (1) | AU653141B2 (fr) |
| CA (2) | CA2074512A1 (fr) |
| DE (1) | DE69025629T2 (fr) |
| ES (1) | ES2082962T3 (fr) |
| FI (1) | FI923348A (fr) |
| NO (1) | NO922941L (fr) |
| WO (2) | WO1991011528A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2044741A1 (fr) * | 1990-06-18 | 1991-12-19 | Jade Chin | Anticorps monoclonaux gp120 anti-vih |
| JP2002530071A (ja) | 1998-11-13 | 2002-09-17 | クラウセン、ヘンリク | ＵＤＰガラクトース：β−Ｎ−アセチル−グルコサミンβ１，３ガラクトシルトランスフェラーゼ、β３Ｇａｌ−Ｔ５ |
| US6800468B1 (en) | 1998-11-13 | 2004-10-05 | Henrik Clausen | UDP-galactose: β-N-acetyl-glucosamine β1,3galactosyltransferases, β3Gal-T5 |
| WO2005078443A1 (fr) * | 2004-02-13 | 2005-08-25 | Inverness Medical Switzerland Gmbh | Determination d'infection par la reponse immunitaire a un groupe fonctionnel glucidique |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH083487B2 (ja) * | 1987-07-31 | 1996-01-17 | 株式会社日本抗体研究所 | 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット |
| WO1989008711A1 (fr) * | 1988-03-11 | 1989-09-21 | The Biomembrane Institute | Anticorps monoclonaux et mise au point d'un vaccin developpe contre des antigenes cancereux humains par immunisation avec de la mucine animale et humaine et avec des conjugues porteurs de glucides synthetiques |
-
1990
- 1990-12-13 AT AT91900749T patent/ATE134649T1/de not_active IP Right Cessation
- 1990-12-13 CA CA002074512A patent/CA2074512A1/fr not_active Abandoned
- 1990-12-13 DE DE69025629T patent/DE69025629T2/de not_active Expired - Fee Related
- 1990-12-13 AU AU69614/91A patent/AU653141B2/en not_active Ceased
- 1990-12-13 EP EP91900749A patent/EP0511967B1/fr not_active Expired - Lifetime
- 1990-12-13 ES ES91900749T patent/ES2082962T3/es not_active Expired - Lifetime
- 1990-12-13 JP JP91501229A patent/JPH05506565A/ja active Pending
- 1990-12-13 WO PCT/EP1990/002161 patent/WO1991011528A1/fr active IP Right Grant
-
1991
- 1991-01-24 EP EP19910903499 patent/EP0512023A4/en not_active Ceased
- 1991-01-24 CA CA002073459A patent/CA2073459A1/fr not_active Abandoned
- 1991-01-24 WO PCT/US1991/000373 patent/WO1991011199A1/fr not_active Application Discontinuation
- 1991-01-24 JP JP91503601A patent/JPH05506843A/ja active Pending
-
1992
- 1992-07-23 FI FI923348A patent/FI923348A/fi not_active Application Discontinuation
- 1992-07-24 NO NO92922941A patent/NO922941L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69025629T2 (de) | 1996-07-04 |
| WO1991011528A1 (fr) | 1991-08-08 |
| EP0512023A4 (en) | 1993-06-30 |
| FI923348A0 (fi) | 1992-07-23 |
| DE69025629D1 (de) | 1996-04-04 |
| WO1991011199A1 (fr) | 1991-08-08 |
| EP0511967B1 (fr) | 1996-02-28 |
| JPH05506565A (ja) | 1993-09-30 |
| ATE134649T1 (de) | 1996-03-15 |
| EP0511967A1 (fr) | 1992-11-11 |
| AU653141B2 (en) | 1994-09-22 |
| CA2074512A1 (fr) | 1991-07-27 |
| JPH05506843A (ja) | 1993-10-07 |
| NO922941D0 (no) | 1992-07-24 |
| FI923348A (fi) | 1992-07-23 |
| CA2073459A1 (fr) | 1991-07-27 |
| ES2082962T3 (es) | 1996-04-01 |
| EP0512023A1 (fr) | 1992-11-11 |
| AU6961491A (en) | 1991-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944475D0 (no) | Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener | |
| NO302176B1 (no) | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen | |
| EP0867451A3 (fr) | Anticorps monoclonaux contre des régions définies du récepteur de cellules T | |
| EP0415920A4 (en) | Monoclonal antibody specific to hiv antigens | |
| DK98187D0 (da) | Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma | |
| CA2004478A1 (fr) | Anticorps monoclonaux contre le lentivirus t-lymphotrope felin | |
| DK0474691T3 (da) | Monoklonale antistoffer til induktion af tolerance | |
| DK282987A (da) | Lagdelt immunoanalyseorgan til bestemmelse af et antigens tilstedevaerelse, og hvori der anvendes antistoffer beregnet til transport af partikler | |
| AU525403B2 (en) | Purified antigen | |
| NO922941L (no) | Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener | |
| ATE119203T1 (de) | Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. | |
| DE3485712D1 (de) | Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren. | |
| DK140992D0 (da) | Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug | |
| EP0323802A3 (fr) | Anticorps monoclonaux contre, et antigène de la surface cellulaire de cancer du poumon | |
| EP0511300A4 (en) | Monoclonal antibody specific for non-immunodominant epitope of hiv proteins | |
| ATE2048T1 (de) | Isolierung von hepatitis be-antigen. | |
| EP0293184A3 (fr) | Essais immunodiagnostiques utilisant les antigènes chimériques | |
| DK0537168T3 (da) | Antigenet CTAA 28A32, som genkendes af MCA 28A32 | |
| DE3854926D1 (de) | Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel | |
| ES2059539T3 (es) | Metodo para la prevencion de la enfermedad del injerto frente al huesped. | |
| IT1254570B (it) | Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione. | |
| AU1508088A (en) | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use | |
| EP0334076A3 (en) | Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same | |
| EP0347230A3 (fr) | Miniclones | |
| NO900609L (no) | Monoclonale antistoffer mot epiteliale linseceller og fremgangsmaater for forhindring av formering av epiteliale linserestceller etter ekstrakapsulaer ekstraksjon. |